BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17097792)

  • 1. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
    Eckert S; Eyer P; Worek F
    Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
    Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods.
    Eckert S; Eyer P; Melzer M; Thiermann H; Worek F
    Biochem Pharmacol; 2008 Apr; 75(7):1561-6. PubMed ID: 18281016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
    Herkert NM; Thiermann H; Worek F
    Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro.
    Herkert NM; Schulz S; Wille T; Thiermann H; Hatz RA; Worek F
    Toxicol Appl Pharmacol; 2011 May; 253(1):7-13. PubMed ID: 21402092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
    Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Eckert S; Eyer P; Herkert N; Bumm R; Weber G; Thiermann H; Worek F
    Biochem Pharmacol; 2008 Feb; 75(3):698-703. PubMed ID: 17977518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
    Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
    Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a dynamic model for real-time determination of membrane-bound acetylcholinesterase activity upon perfusion with inhibitors and reactivators.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):358-65. PubMed ID: 16725113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
    Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of atropine upon ageing and reactivation of soman inhibited acetylcholinesterase from human erythrocytes. Preliminary communication.
    Kuhnen H; Schrichten A; Schoene K
    Arzneimittelforschung; 1985; 35(9):1454-6. PubMed ID: 4084346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of pharmacologic prophylaxis with Panpal on acetylcholinesterase activity in the diaphragm and various parts of the brain in rats during treated and untreated Soman poisoning].
    Kassa J
    Cas Lek Cesk; 1998 May; 137(10):299-302. PubMed ID: 9650360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxication.
    Øydvin OK; Tansø R; Aas P
    Eur J Pharmacol; 2005 Jun; 516(3):227-34. PubMed ID: 15967427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
    Hamilton LR; Schachter SC; Myers TM
    Neurochem Res; 2017 Jul; 42(7):1962-1971. PubMed ID: 27900576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Musilova L; Kuca K; Jung YS; Jun D
    Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
    Szegletes T; Mallender WD; Rosenberry TL
    Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.